Ruyssen-Witrand A - Search Results

1

Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism.

Degboé Y, Rauwel B, Baron M, Boyer JF, Ruyssen-Witrand A, Constantin A, Davignon JL. Degboé Y, et al. Front Immunol. 2019 Jan 18;10:3. doi: 10.3389/fimmu.2019.00003. eCollection 2019. Front Immunol. 2019. PMID: 30713533 Free PMC article.

2

Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries.

Sousa M, Lubrano E, Smolen JS, Gorlier C, de Wit M, Coates LC, Kalyoncu U, Ruyssen-Witrand A, Leung YY, Scrivo R, Cañete JD, Palominos P, Meisalu S, Balanescu A, Kiltz U, Aydin SZ, Gaydukova I, Dernis E, Fautrel B, Orbai AM, Gossec L. Sousa M, et al. Joint Bone Spine. 2023 May;90(3):105511. doi: 10.1016/j.jbspin.2022.105511. Epub 2022 Dec 15. Joint Bone Spine. 2023. PMID: 36529417

3

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab.

Ruyssen-Witrand A, Rouanet S, Combe B, Dougados M, Le Loët X, Sibilia J, Tebib J, Mariette X, Constantin A. Ruyssen-Witrand A, et al. Ann Rheum Dis. 2012 Jun;71(6):875-7. doi: 10.1136/annrheumdis-2011-200337. Epub 2012 Feb 25. Ann Rheum Dis. 2012. PMID: 22368231 Clinical Trial.

4

New insights into the genetics of immune responses in rheumatoid arthritis.

Ruyssen-Witrand A, Constantin A, Cambon-Thomsen A, Thomsen M. Ruyssen-Witrand A, et al. Tissue Antigens. 2012 Aug;80(2):105-18. doi: 10.1111/j.1399-0039.2012.01939.x. Tissue Antigens. 2012. PMID: 22835281 Free article. Review.

5

Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients.

Ruyssen-Witrand A, Rouanet S, Combe B, Dougados M, Le Loët X, Sibilia J, Tebib J, Mariette X, Constantin A. Ruyssen-Witrand A, et al. Rheumatology (Oxford). 2013 Apr;52(4):636-41. doi: 10.1093/rheumatology/kes344. Epub 2012 Dec 22. Rheumatology (Oxford). 2013. PMID: 23264555 Clinical Trial.

6

Epistatic interaction between BANK1 and BLK in rheumatoid arthritis: results from a large trans-ethnic meta-analysis.

Génin E, Coustet B, Allanore Y, Ito I, Teruel M, Constantin A, Schaeverbeke T, Ruyssen-Witrand A, Tohma S, Cantagrel A, Vittecoq O, Barnetche T, Le Loët X, Fardellone P, Furukawa H, Meyer O, Fernández-Gutiérrez B, Balsa A, González-Gay MA, Chiocchia G, Tsuchiya N, Martin J, Dieudé P. Génin E, et al. PLoS One. 2013 Apr 30;8(4):e61044. doi: 10.1371/journal.pone.0061044. Print 2013. PLoS One. 2013. PMID: 23646104 Free PMC article.

7

Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts).

Ruyssen-Witrand A, Lukas C, Nigon D, Dawidowicz K, Morel J, Sibilia J, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, Constantin A. Ruyssen-Witrand A, et al. Joint Bone Spine. 2014 May;81(3):228-34. doi: 10.1016/j.jbspin.2013.10.002. Epub 2013 Nov 5. Joint Bone Spine. 2014. PMID: 24200909

8

Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes.

Ruyssen-Witrand A, Guernec G, Nigon D, Tobon G, Jamard B, Rat AC, Vittecoq O, Cantagrel A, Constantin A. Ruyssen-Witrand A, et al. Ann Rheum Dis. 2015 Sep;74(9):1676-83. doi: 10.1136/annrheumdis-2013-204906. Epub 2014 May 2. Ann Rheum Dis. 2015. PMID: 24794151

9

Prevalence of ultrasound-detected residual synovitis and risk of relapse and structural progression in rheumatoid arthritis patients in clinical remission: a systematic review and meta-analysis.

Nguyen H, Ruyssen-Witrand A, Gandjbakhch F, Constantin A, Foltz V, Cantagrel A. Nguyen H, et al. Rheumatology (Oxford). 2014 Nov;53(11):2110-8. doi: 10.1093/rheumatology/keu217. Epub 2014 Jun 13. Rheumatology (Oxford). 2014. PMID: 24929634 Review.

10

A new classification of HLA-DRB1 alleles based on acid-base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort).

Ruyssen-Witrand A, van Steenbergen HW, van Heemst J, Gourraud PA, Nigon D, Lukas C, Miceli-Richard C, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, van der Helm-van Mil AH, Constantin A. Ruyssen-Witrand A, et al. RMD Open. 2015 Nov 19;1(1):e000099. doi: 10.1136/rmdopen-2015-000099. eCollection 2015. RMD Open. 2015. PMID: 26629363 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page